Influenza vaccine (Protein Sciences Corporation)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInfluenza vaccine (Protein Sciences Corporation)
Drug Alias Name流感疫苗（Protein Sciences Corporation）Flublok
ClassificationVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza A virus infectionsInfluenza, HumanInfluenza B virus infection
Global Approved IndicationsInfluenza A virus infectionsInfluenza B virus infection
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2013/01/16
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesProtein Sciences Corporation
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProtein Sciences Corporation
Active IndicationsInfluenza A virus infectionsInfluenza B virus infection
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeJ07BB
Related LinksN/A